Results 191 to 200 of about 9,809,915 (420)

表紙・目次 [PDF]

open access: yes, 1999
Okayama Association for Laboratory Animal Science,
core  

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

open access: yesMolecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam   +9 more
wiley   +1 more source

第21回岡山実験動物研究会 [PDF]

open access: yes, 1992
Okayama Association for Laboratory Animal Science,
core  

Enhancing patient engagement in cancer research: a focus on patient‐centric approaches to scientific discovery

open access: yesMolecular Oncology, EarlyView.
Patient engagement involves actively including patients in healthcare decisions and research to ensure care and studies align with their needs. This approach improves outcomes, trust, and communication while fostering collaboration between patients and professionals.
Estela Cepeda   +3 more
wiley   +1 more source

第14回岡山実験動物研究会報告 [PDF]

open access: yes, 1988
Okayama Association for Laboratory Animal Science,
core  

Home - About - Disclaimer - Privacy